This Week
  • Bitcoin wallet firm Case gets $1.5 million to fund its development.

  • It's not business as usual in building relationships with millennials.

  • Premium Mortgage has grown considerably in the past seven years.

  • MCC Foundation's Diane Shoger knows "how philanthropy works."

  • The 2015 edition features an exclusive interview with Paychex CEO Martin Mucci.

  • Chelsea Knapp has transitioned from collegiate hockey goalie to financial adviser.

Trulign lens by B&L gets FDA approval

Rochester Business Journal
May 21, 2013

Bausch & Lomb Inc. has received U.S. Food and Drug Administration approval for its Trulign lens, company officials said Tuesday.

Meant for cataract and other eye-surgery patients, the Trulign lens corrects astigmatic blurred vision, which can be an unwanted side effect of artificial lens implantation.  According to the eye-care company, it is the first toric intraocular lens that can correct astigmatism and deliver improved vision across a natural range of focus as well.   
 
(c) 2013 Rochester Business Journal. To obtain permission to reprint this article, call 585-546-8303 or e-mail service@rbj.net.
 


What You're Saying 

There are no comments yet. Be the first to add yours!

Post Your Own Comment

 
Username:
Password:

Not registered? Sign up now!
 

To Do   Text Size
Post CommentPost A Comment eMail Size1
View CommentsView All Comments PrintPrint Size2
ReprintsReprints Size3
  • E-mailed
  • Commented
  • Viewed
RBJ   Google